VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 165 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $333,000 | +14.0% | 22,200 | 0.0% | 0.01% | +20.0% |
| Q4 2020 | $292,000 | +36.4% | 22,200 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $214,000 | -15.7% | 22,200 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $254,000 | +10.4% | 22,200 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $230,000 | -36.8% | 22,200 | 0.0% | 0.01% | -25.0% |
| Q4 2019 | $364,000 | +96.8% | 22,200 | +59.7% | 0.01% | +100.0% |
| Q3 2019 | $185,000 | +105.6% | 13,900 | +117.2% | 0.00% | +100.0% |
| Q2 2019 | $90,000 | -23.7% | 6,400 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $118,000 | -29.3% | 6,400 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $167,000 | – | 6,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |